212 related articles for article (PubMed ID: 17109975)
1. Highly selective action of triphosphate metabolite of 4'-ethynyl D4T: a novel anti-HIV compound against HIV-1 RT.
Yang G; Dutschman GE; Wang CJ; Tanaka H; Baba M; Anderson KS; Cheng YC
Antiviral Res; 2007 Mar; 73(3):185-91. PubMed ID: 17109975
[TBL] [Abstract][Full Text] [Related]
2. Mechanism of inhibition of human immunodeficiency virus type 1 reverse transcriptase by a stavudine analogue, 4'-ethynyl stavudine triphosphate.
Yang G; Wang J; Cheng Y; Dutschman GE; Tanaka H; Baba M; Cheng YC
Antimicrob Agents Chemother; 2008 Jun; 52(6):2035-42. PubMed ID: 18391035
[TBL] [Abstract][Full Text] [Related]
3. Impact of novel human immunodeficiency virus type 1 reverse transcriptase mutations P119S and T165A on 4'-ethynylthymidine analog resistance profile.
Yang G; Paintsil E; Dutschman GE; Grill SP; Wang CJ; Wang J; Tanaka H; Hamasaki T; Baba M; Cheng YC
Antimicrob Agents Chemother; 2009 Nov; 53(11):4640-6. PubMed ID: 19704131
[TBL] [Abstract][Full Text] [Related]
4. Intracellular metabolism and persistence of the anti-human immunodeficiency virus activity of 2',3'-didehydro-3'-deoxy-4'-ethynylthymidine, a novel thymidine analog.
Paintsil E; Dutschman GE; Hu R; Grill SP; Lam W; Baba M; Tanaka H; Cheng YC
Antimicrob Agents Chemother; 2007 Nov; 51(11):3870-9. PubMed ID: 17724147
[TBL] [Abstract][Full Text] [Related]
5. Balancing antiviral potency and host toxicity: identifying a nucleotide inhibitor with an optimal kinetic phenotype for HIV-1 reverse transcriptase.
Sohl CD; Kasiviswanathan R; Kim J; Pradere U; Schinazi RF; Copeland WC; Mitsuya H; Baba M; Anderson KS
Mol Pharmacol; 2012 Jul; 82(1):125-33. PubMed ID: 22513406
[TBL] [Abstract][Full Text] [Related]
6. Anti-human immunodeficiency virus type 1 activity and resistance profile of 2',3'-didehydro-3'-deoxy-4'-ethynylthymidine in vitro.
Nitanda T; Wang X; Kumamoto H; Haraguchi K; Tanaka H; Cheng YC; Baba M
Antimicrob Agents Chemother; 2005 Aug; 49(8):3355-60. PubMed ID: 16048947
[TBL] [Abstract][Full Text] [Related]
7. Structure of HIV-1 reverse transcriptase/d4TTP complex: Novel DNA cross-linking site and pH-dependent conformational changes.
Martinez SE; Bauman JD; Das K; Arnold E
Protein Sci; 2019 Mar; 28(3):587-597. PubMed ID: 30499174
[TBL] [Abstract][Full Text] [Related]
8. Insights into the molecular mechanism of inhibition and drug resistance for HIV-1 RT with carbovir triphosphate.
Ray AS; Yang Z; Shi J; Hobbs A; Schinazi RF; Chu CK; Anderson KS
Biochemistry; 2002 Apr; 41(16):5150-62. PubMed ID: 11955063
[TBL] [Abstract][Full Text] [Related]
9. The role of steric hindrance in 3TC resistance of human immunodeficiency virus type-1 reverse transcriptase.
Gao HQ; Boyer PL; Sarafianos SG; Arnold E; Hughes SH
J Mol Biol; 2000 Jul; 300(2):403-18. PubMed ID: 10873473
[TBL] [Abstract][Full Text] [Related]
10. Mechanism of inhibition of the human immunodeficiency virus type 1 reverse transcriptase by d4TTP: an equivalent incorporation efficiency relative to the natural substrate dTTP.
Vaccaro JA; Parnell KM; Terezakis SA; Anderson KS
Antimicrob Agents Chemother; 2000 Jan; 44(1):217-21. PubMed ID: 10602755
[TBL] [Abstract][Full Text] [Related]
11. Partial selective inhibition of HIV-1 reverse transcriptase and human DNA polymerases γ and β by thiated 3'-fluorothymidine analogue 5'-triphosphates.
Wińska P; Miazga A; Poznański J; Kulikowski T
Antiviral Res; 2010 Nov; 88(2):176-81. PubMed ID: 20739003
[TBL] [Abstract][Full Text] [Related]
12. Dissecting the effects of DNA polymerase and ribonuclease H inhibitor combinations on HIV-1 reverse-transcriptase activities.
Shaw-Reid CA; Feuston B; Munshi V; Getty K; Krueger J; Hazuda DJ; Parniak MA; Miller MD; Lewis D
Biochemistry; 2005 Feb; 44(5):1595-606. PubMed ID: 15683243
[TBL] [Abstract][Full Text] [Related]
13. Anti-human immunodeficiency virus type 1 activity, intracellular metabolism, and pharmacokinetic evaluation of 2'-deoxy-3'-oxa-4'-thiocytidine.
de Muys JM; Gourdeau H; Nguyen-Ba N; Taylor DL; Ahmed PS; Mansour T; Locas C; Richard N; Wainberg MA; Rando RF
Antimicrob Agents Chemother; 1999 Aug; 43(8):1835-44. PubMed ID: 10428900
[TBL] [Abstract][Full Text] [Related]
14. Single-step kinetics of HIV-1 reverse transcriptase mutants responsible for virus resistance to nucleoside inhibitors zidovudine and 3-TC.
Krebs R; Immendörfer U; Thrall SH; Wöhrl BM; Goody RS
Biochemistry; 1997 Aug; 36(33):10292-300. PubMed ID: 9254628
[TBL] [Abstract][Full Text] [Related]
15. Retention of metabolites of 2',3'-didehydro-3'-deoxy-4'-ethynylthymidine, a novel anti-human immunodeficiency virus type 1 thymidine analog, in cells.
Wang X; Tanaka H; Baba M; Cheng YC
Antimicrob Agents Chemother; 2009 Aug; 53(8):3317-24. PubMed ID: 19470503
[TBL] [Abstract][Full Text] [Related]
16. Perspectives on the molecular mechanism of inhibition and toxicity of nucleoside analogs that target HIV-1 reverse transcriptase.
Anderson KS
Biochim Biophys Acta; 2002 Jul; 1587(2-3):296-9. PubMed ID: 12084471
[TBL] [Abstract][Full Text] [Related]
17. Three-drug combinations of emivirine and nucleoside reverse transcriptase inhibitors in vitro: long-term culture of HIV-1-infected cells and breakthrough viruses.
Nitanda T; Wang X; Somekawa K; Yuasa S; Baba M
Antivir Chem Chemother; 2001 May; 12(3):161-7. PubMed ID: 12959324
[TBL] [Abstract][Full Text] [Related]
18. A conformationally locked analogue of the anti-HIV agent stavudine. An important correlation between pseudorotation and maximum amplitude.
Choi Y; George C; Comin MJ; Barchi JJ; Kim HS; Jacobson KA; Balzarini J; Mitsuya H; Boyer PL; Hughes SH; Marquez VE
J Med Chem; 2003 Jul; 46(15):3292-9. PubMed ID: 12852759
[TBL] [Abstract][Full Text] [Related]
19. Molecular mechanism by which the K70E mutation in human immunodeficiency virus type 1 reverse transcriptase confers resistance to nucleoside reverse transcriptase inhibitors.
Sluis-Cremer N; Sheen CW; Zelina S; Torres PS; Parikh UM; Mellors JW
Antimicrob Agents Chemother; 2007 Jan; 51(1):48-53. PubMed ID: 17088490
[TBL] [Abstract][Full Text] [Related]
20. The nucleoside analogs 4'C-methyl thymidine and 4'C-ethyl thymidine block DNA synthesis by wild-type HIV-1 RT and excision proficient NRTI resistant RT variants.
Boyer PL; Julias JG; Ambrose Z; Siddiqui MA; Marquez VE; Hughes SH
J Mol Biol; 2007 Aug; 371(4):873-82. PubMed ID: 17597154
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
